VIA Pharmaceuticals, Inc.

OTC: VIAP · Healthcare · Medical - Pharmaceuticals

PublicHQ San Francisco, Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 36

v0.1 · 5/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ Piotroski F, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$9.6M

Employees

Market cap

$10.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02010

Net income-$9.6M-$9.6M2010

Operating income-$6.0M-$6.0M2010

Total assets$500.0k$500.0k2010

Liabilities$19.0M$19.0M2010

Equity-$18.5M-$18.5M2010

Revenue trend

FY2003 – FY2010 · USD

$34.7k

FY03

$83.3k

FY04

$83.3k

FY05

$83.3k

FY06

FY07

FY08

FY09

FY10

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

VIA Pharmaceuticals, Inc. booked $0 in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Ehouse Global, Inc.——OneLife Technologies Corp.——Navidea Biopharmaceuticals, Inc.——GeneLink, Inc.——

Key facts

CEOThomas Quertermous

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersSan Francisco, null

ExchangeOTC: VIAP

Employees6

IPO date2007-06-06

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.